Forest Road Acquisition Corp. (FRX) – StreetInsider.com Reports
-
Fennec Pharmaceuticals (FENC) Announces Commercial Availability of PEDMARKĀ® (sodium thiosulfate injection) in the United States
-
Fennec Pharmaceuticals (FENC) Confirms FDA Approval of PEDMARK
-
Forest Road Acquisition Corp. (FRX) Stockholders Approve Proposed Merger With The Beachbody Company and Myx Fitness
-
Forest Road Acquisition Corp., (FRX) The Beachbody Company and Myx Fitness Announce Expected Closing of Business Combination (BODY)
-
UPDATE: DA Davidson Starts SPAC Forest Road Acquisition (FRX) at Buy Into Pending Merger with Beachbody
-
UPDATE: Loop Capital Starts Forest Laboratories (FRX) at Hold
-
Fennec Pharmaceuticals (FENC) Resubmits NDA to U.S. Food and Drug Administration for PEDMARK
-
IPO for SPAC Forest Road Acquisition Corp. II (FRXB) Opens at $10.02
-
The Beachbody Company and Nutrition Solutions to Become Publicly Traded Company Via Merger with Forest Road Acquisition Corp. (FRX)
-
Forest Road Acquisition Corp. (FRX) Prices 26.1M Unit Upsized IPO $10/Unit
-
Fennec Pharma (FENC) Receives CRL from FDA for its NDA for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
-
Fennec Pharmaceuticals (FENC) Prices 4.8M Common Stock Offering at $6.25/Share
-
Fennec Pharmaceuticals (FENC) Announces Proposed Public Offering of Common Shares
-
Fennec Pharmaceuticals (FENC) Reports FDA Filing Acceptance and Priority Review of NDA for PEDMARK
-
Fennec Pharmaceuticals (FENC) Granted U.S. Patent for Use of PEDMARK
-
Fennec Pharmaceuticals (FENC) Prices 2.35M Common Stock Offering at $8.50/Share
-
Fennec Pharmaceuticals (FENC) to Offer Common Stock
-
Fennec (FENC) Says Prelim. Results of SIOPEL 6 Study on PEDMAR to be Presented at SIOP Meeting
-
Carl Icahn 13F Shows Lowered Stake in Netflix (NFLX), Higher eBay (EBAY) (MORE...)
-
Actavis (ACT) Completes $28B Acqusition of Forest Laboratories (FRX)
-
Actavis (ACT), Forest (FRX) Proposed Merger Approved by FTC
-
Pre-Open Stock Movers 6/25: (MDCI) (AERI) (NSPH) Higher; (ATNM) (VMI) (TISI) Lower (more...)
-
After-Hours Stock Movers 6/24: (IMS) (AMG) (BMY) Higher; (ATNM) (VMI) (TISI) Lower (more...)
-
Market Wrap: Consumers More Confident in May; Vertex Rips on CF Drug Results; One 'Crazy' IPO
-
Affiliated Managers Group (AMG) Set to Join S&P 500; LaSalle Hotel Properties (LHO), Rayonier Advanced Materials (RYAM), TimkenSteel (TMST), Belden (BDC) to Join the S&P MidCap 400; Others to Join S&P
-
Forest Labs (FRX) Reports Vilazodone Met Primary Endpoint in Phase III
-
Actavis (ACT), Forest Labs (FRX) Appoint C. David Nicholson as SVP, Actavis Global Brands R&D
-
Actavis (ACT), Forest (FRX) Holders Approve All Proposals
-
Furiex Pharmaceuticals (FURX) Sets July 1 Special Meeting Date Related to Forest Labs (FRX) Merger
-
Forest Laboratories (FRX) Says Data Published on Ph-3 FDC of Nebivolol and Valsartan
-
Carl Icahn Releases Q1 13F; Boosts Apple (AAPL) Stake to 7.5M
-
Actavis (ACT) Announces Executive Leadership Shift Upon Closing of Forest Labs (FRX) Deal
-
Forest Laboratories, Inc. (FRX) Posts Q4 adj.-EPS of 87c
-
Market Wrap: BofA Rethinks Capital Plan; Two Mergers Dematerialize; Alstom Attracts Siemens Eye
-
Trading Radar for 04/29: eBay (EBAY), Twitter (TWTR), Nokia (NOK), Express Scripts (ESRX), Seagate (STX) Report
-
Unusual 11 Mid-Day Movers 04/28: (SUSS) (FURX) (SUSP) Higher; (ATHX) (OGXI) (ELTK) Lower
-
Notable Mergers and Acquisitions of the Day 04/28: (PFE)/(AZN) (ABX)/(NEM) (FRX)/(FURX) (ETP)/(SUSS)
-
Pre-Open Stock Movers 4/28: (SUSS) (FURX) (AZN) Higher; (ATHX) (OGXI) (POZN) Lower (more...)
-
Forest Labs (FRX) to Acquire Furiex Pharma (FURX) in ~$1.46B Deal
-
Market Wrap: Initial Claims Show Modest Gain; GE Bring on Q1 Beat; Wal-mart Gets into Money-Transfer Game
-
Actavis (ACT), Forest Labs (FRX) Report Receipt of Second Info Request Under HSR Act
-
Forest Labs (FRX), Almirall Plan Type C Meeting with U.S. FDA Over Aclidinium + Formoterol Combo
-
Forest Labs (FRX), Gedeon Richter Reports Positive Antipsychotic Cariprazine Phase IIb Results
-
Credit Suisse Downgrades Forest Laboratories (FRX) to Neutral
-
Forest Labs (FRX) Submits NDA to FDA for Memantine HCl ER
-
Forest Labs (FRX) Submits NDA to FDA to FDC of Nebivolol and Valsartan
-
Credit Suisse Downgrades Forest Laboratories (FRX) to Neutral
-
Top 10 News for 02/18 to 02/21: Facebook Knows WhatsApp; Tesla Revs on Results; Zynga Rival Files IPO
-
SunTrust Downgrades Forest Laboratories (FRX) to Neutral
-
Developing Trend in M&A Suggests More Deals
Back to FRX Stock Lookup